This brief report examines aortic valve replacement (AVR) options — mechanical, bioprosthetic, and the Ross procedure — in women of reproductive age, drawing on registry data (Swedish Cardiac Surgery Registry / SWEDEHEART) and current guideline recommendations.
Full quantitative results are not available from the publisher page text; however, the study addresses the trade-offs between valve types in this population, including risks of anticoagulation with mechanical valves during pregnancy and structural valve deterioration with bioprosthetics.
Only the publisher page and reference list are accessible — full text, sample size, outcome data, and follow-up duration are not extractable. The Swedish registry setting may limit generalizability to other populations.
When counseling women of reproductive age with aortic valve disease, weigh the teratogenic and thromboembolic risks of anticoagulation with mechanical valves against the higher reoperation risk of bioprosthetics; the Ross procedure is an increasingly guideline-supported alternative. A multidisciplinary team discussion — including cardiology, cardiac surgery, and obstetrics — is essential before any valve choice is made.
Explore related topics
